Stop FDA EUA of Pfizer’s CV-19 for Children

The clinical trial failed in this age group. We have a few days to tell the U.S. Food and Drug Administration to DENY the Emergency Use Authorization of Pfizer’s CV vaccine for this age Group.

On January 31, 2022 it was announced that Pfizer would request FDA Emergency Use Authorization for it’s CV Vaccine for children 6 Months – 4 Years Old. Pfizer seeks to add it’s mRNA vaccine to the official immunization schedule for children, and if so, will have liability protection.

The Pfizer mRNA vaccine in children 2- 4 Years Old failed in a clinical trial. Acting FDA Commissioner, Janet Woodcock, following orders from the Biden Administration made the following statement:

Not to worry about the fact that the shot does not work, we’ve got a drug to sell, submit an Emergency Use Authorization (EUA) application anyway.

Read FDA Commissioner Janet Woodcock’s statement here here

On  Tuesday (Feb. 1) Pfizer submitted an EUA application for children six-months to four-years old.

Pfizer and the FDA are proposing to start with two shots in this age group even though that approach has already failed and then they will add a third dose later in the spring if data comes in that supports that use. The plan is literally — shoot up kids first, get the data later. This approach is completely unprecedented in the history of the FDA and it must be stopped.

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet in two weeks — on February 15 — to evaluate this EUA application for a product that failed the clinical trial.

We need EVERYONE to submit your comment and tell the FDA to DENY the Emergency Use Authorization for the Pfizer CV Vaccine for Children 6 months old to 4 years old.